Aseptic osteonecrosis risk with oral bisphosphonates

Author：

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1186, 2008-01, pp. : 5-5

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bisphosphonates: dental disorders a risk factor for jaw osteonecrosis

Inpharma, Vol. 1, Iss. 1499, 2005-01 ,pp. : 20-20

Adis International

Access to resources Recommend Favorite

Oral bisphosphonates not linked to oesophageal cancer risk

Reactions Weekly, Vol. 1, Iss. 1315, 2010-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Pharmacological management of aseptic osteonecrosis in children

By Petje Gert Radler Christof Aigner Nicolas Manner Hannes Kriegs-Au Gabriele Grill Franz

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 7, 2004-07 ,pp. : 1455-1462

Informa Healthcare

Access to resources Recommend Favorite

Dexamethasone/prednisolone: Aseptic osteonecrosis: case report

Reactions Weekly, Vol. 1, Iss. 1386, 2012-01 ,pp. : 17-18

Adis International

Access to resources Recommend Favorite

Bisphosphonates: Osteonecrosis of the jaw: 2 case reports

Reactions Weekly, Vol. 1, Iss. 1256, 2009-01 ,pp. : 10-11

Adis International

Access to resources Recommend Favorite